Screening

Diagnostic screening programs help catch cancer, abnormalities or other diseases before they reach an advanced stage, saving lives and healthcare costs. Screening programs include, lung, breast, prostate, and cervical cancer, among many others.

AI model nearly halves false positive rates for lung cancer CT screenings
Reducing false positives could decrease the frequency of unnecessary procedures, lower the associated costs and also ease patient anxiety concerning CT results.
AI for opportunistic osteoporosis screening inks FDA clearance
The tool analyzes routine hip and pelvis X-rays for signs of low bone mineral density.
Emphysema on baseline lung cancer CT a sign of future mortality risk
“Lung cancer screening shouldn’t just be looking for nodules. That’s a small part of what we see on the CT scan.”
Exploring the link between left ventricular diastolic function and AFib
Evaluating LVDF with echocardiography or AI-powered electrocardiography can help identify individuals at an increased risk of developing atrial fibrillation, according to new data presented at the ASE 36th Annual Scientific Sessions.
Late-stage prostate cancer diagnoses on the rise
Experts say these new findings highlight the need for more effective screening initiatives among men who may face access barriers.

Research offers new guidance on managing architectural distortion visualized on DBT exams

Multiple areas of architectural distortion visualized on digital breast tomosynthesis (DBT) exams are likely to produce high-risk pathology results.

The National Comprehensive Cancer Network has published new patient-friendly breast cancer screening guidelines

The new guidelines put emphasis on the age at which average-risk women should begin annual screening and breast assessments.

Despite mandated coverage, nearly half of women are concerned about OOP breast cancer screening expenses

Women who skipped screening due to financial concerns outnumbered those who were not screened due to logistical issues such as scheduling and transportation conflicts, new survey data reveals.

Imaging surveillance program detects pancreatic cancer in its earliest stages

Individuals at high risk of pancreatic cancer benefit from annual imaging and have decreased mortality rates compared to those who forgo preventive screening.

CMS shoots down request to reconsider CTC cancer screening coverage

In the June 29 announcement, the ACR revealed CMS said the additional evidence provided to them was “insufficient” to support the reconsideration of their non-coverage decision.

Screening mammograms are not as effective as they once were

This is a trend that researchers believe will persist as disease management continues to improve.

A comparison of standard 2D mammography (right) and digital breast tomosynthesis (DBT), or 3D mammography (left). The DBT creates a data set of 1 mm slices that the radiologist can look through to see more detail in suspect areas and determine if it dense breast tissue is masking a tumor.

DBT is better for women with increased breast cancer risks

For the research, special attention was paid to women with dense breasts and other factors that raise their risk of a breast cancer diagnosis.

Example of various breast MRI protocol sequences that offer different types of soft tissue enhancement. Imaging performed on a Siemens Magnetom system. Breast MRI can help see through dense breast tissue to better detect cancers. #densebreasts #Breastdensity #BreastMRI

Contrast enhanced breast MRI superior to CEM, but accessibility remains an obstacle

In addition to CE-MRI's increased sensitivity for identifying breast cancers, the researchers also found the modality had superior negative likelihood ratios with higher pre-test probabilities for safely ruling out malignancy.

Screening

AI model nearly halves false positive rates for lung cancer CT screenings

AI for opportunistic osteoporosis screening inks FDA clearance

Emphysema on baseline lung cancer CT a sign of future mortality risk

Exploring the link between left ventricular diastolic function and AFib

Late-stage prostate cancer diagnoses on the rise